Frontiers in Pharmacology | Translational Pharmacology

Original Research

Published on 18 Aug 2025

Published population pharmacokinetic models of mycophenolate sodium: a systematic review and external evaluation in a Chinese sample of renal transplant recipients

in Translational Pharmacology

Tong Gao
Wen Xu
Xiao Li
Qie Guo
Donghua Liu
Xiaolei Zhang
Ping Leng
Jialin Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632568

Review

Accepted on 15 Aug 2025

PART II -IMIDAZOLINES & RHINITIS MEDICAMENTOSA: How can we tackle the Rebound Dilemma?

in Translational Pharmacology

Rebecca Stinson
Laura Sadofsky

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1655254

Review

Accepted on 15 Aug 2025

Efficacy and safety of pregabalin in the management of low back pain: a comprehensive meta-analysis

in Translational Pharmacology

Carlos Cordero
Judith Sanchez-Raya
Tamara Rodriguez
Lola Lopez Alarcon
Eva Trillo
Balsalobre Aznar Jeronimo
Maria Perez-Paramo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1659531

Original Research

Published on 15 Aug 2025

Global research trends on ALK-TKIs in non-small cell lung cancer: a bibliometric analysis

in Translational Pharmacology

Yafeng Liu
Zhaojin Han
Yujia Li
Pengfei Zhang
Qiushi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1665174

373 views

Original Research

Accepted on 13 Aug 2025

Investigating the Feasibility of Machine Learning to Guide Personalized Red Blood Cell (RBC) Transfusion: Analyzing the Heterogeneity of RBC Transfusion in Septic Patients with Hemoglobin Levels of 7-9 g/dL Based on the Causal Forest Model

in Translational Pharmacology

Penglei Yang
Jun Yuan
Jie He
Lina Yu
Xue gu
Xizhen Ding
Qihong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1615618

139 views

Original Research

Accepted on 12 Aug 2025

Locked Nucleic Acid-Modified Antisense Oligonucleotides Attenuate Scar Hyperplasia through Targeted Inhibition of CTGF

in Translational Pharmacology

Jinhe Li
Xi Wu
Ying Yang
Ruiqi Mao
Zherui Li
Xiujun Zhang
Wenguo Wei
Wendi Wang
Hailong Li
Honggang Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1623640

113 views

Original Research

Published on 12 Aug 2025

A case–control study on the individualized use of opioid analgesics based on single-nucleotide polymorphism

in Translational Pharmacology

Jing Yang
Lei Zheng
Fu Zheng
Shu-Han Zhou
Liang-Wei Sun
Chao Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1629866

283 views

Original Research

Accepted on 11 Aug 2025

Effect of ketamine on cellular immunity and inflammation in patients who undergo laparoscopic colon cancer surgery: A retrospective study

in Translational Pharmacology

Jiajia Ji
Haiping Zhang
Lixia Zhou
Chunlan Fan
Ligen Dai
Shaolei Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562122

356 views

Review

Accepted on 11 Aug 2025

Targeted Photodynamic Therapy: Enhancing Efficacy through Specific Organelle Engagement

in Translational Pharmacology

Jiawen Tao
Zhifei Yuan
Mengjiao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1667812

Review

Accepted on 11 Aug 2025

Retrospective Evaluation of Resident Pharmacists' Services in a Liver Intensive Care Unit: A Single-Center Experience

in Translational Pharmacology

Huijie Meng
Zhaoshuai Ji
Zhenyu Zhang
Yuanyuan Liu
Fang Li
Jing Tang
Guangmeng Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1583818

Original Research

Accepted on 11 Aug 2025

Differential Carbon Source Utilization Drives Metabolic State and Resuscitation in Antibiotic-Tolerant Persister Cells

in Translational Pharmacology

Yufei Sun
Sweta Roy
Qingbo Yang
Yinjie J Tang
Dacheng Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1634627

Review

Published on 11 Aug 2025

From neuromodulation to bone homeostasis: therapeutic targets of nerve growth factor in skeletal diseases

in Translational Pharmacology

Kaixuan Chen
Longjun Chen
Yizhong Ma
Siqi Chen
Jinze Liu
Hangyu Zhou
Yuzhu Chen
Guanyi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614542

369 views

Original Research

Published on 01 Aug 2025

Healthy participant engagement in early clinical trials: results from the European EUFEMED survey

in Translational Pharmacology

J. Klein
T. van Iersel
D. de Vries
Y. Donazzolo
I. Klingmann

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540948

567 views

Original Research

Accepted on 31 Jul 2025

Pharmacokinetics and safety of highly variable Nitroglycerin Lingual Spray (NLS) versus US-Licensed Nitroglycerin Lingual Spray Reference Product (Nitrolingual®): a randomized, four-cycle, four-sequence, partially replicated crossover phase I bioequivalence clinical trial

in Translational Pharmacology

Yingying Fang
Lu Qi
Yu Wang
Chunyu Han
Qian Zhang
Xiaoyun Liu
Ju Liu
Xiaoqiang Cheng
Yinjuan Li
Yan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1631341

152 views

Original Research

Published on 31 Jul 2025

Ultrasound combined with microbubble enhanced renoprotective effects of NLRP3 inflammasome inhibitor MCC950 in CKD model

in Translational Pharmacology

Wen Wen
Bin Tu
Xiaomei Ren
Yangli Liu
Rufang Jiang
Xiaofeng Wu
Jian Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1616542

316 views

Original Research

Accepted on 30 Jul 2025

Safety,Tolerability,Pharmacokinetics,Immunogenicity and Pharmacodynamics of 9MW1911, an Anti-ST2 Monoclonal Antibody: Results from a First-in-Human Phase 1 Study

in Translational Pharmacology

Qian Zhao
Qian Li
Yucan Wang
Li Li
Xue Zhao
Ni Wu
Diyi Fu
Danfeng Yin
Jing Feng
Zhitian Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1647816

270 views